(NASDAQ: PETS) Petmed Express's forecast annual revenue growth rate of -5.73% is not forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of 0.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.68%.
Petmed Express's revenue in 2025 is $247,010,000.On average, 1 Wall Street analysts forecast PETS's revenue for 2026 to be $4,402,820,527, with the lowest PETS revenue forecast at $4,402,820,527, and the highest PETS revenue forecast at $4,402,820,527.
In 2027, PETS is forecast to generate $4,534,236,907 in revenue, with the lowest revenue forecast at $4,534,236,907 and the highest revenue forecast at $4,534,236,907.